A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors
Clinical trial NCT03257631 · COMPLETED
Trial details
- NCT number
- NCT03257631
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2023-09-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.